Behavioral
The Children's Doctor
The Children's Doctor was paid $9.61M by Medicaid between Jan 2018 and Dec 2024, across 77 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoTHE CHILDREN'S DOCTOR
HAGERSTOWN, MD 21740
HAGERSTOWN, MD 21740
33aNPI1639208994assigned 03/05/2007
33bProvider typeClinical Social Worker
28Total paid$9.61M
24GClaims238,433
24DCodes billed77
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Social Worker providers in Maryland
Rank by total paid#4 of 580
Median peer was paid$40K
This provider vs. median240×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 666 | $17K | |
| 2019 | 819 | $20K | |
| 2020 | 37,368 | $1.41M | |
| 2021 | 40,439 | $1.53M | |
| 2022 | 44,776 | $2.21M | |
| 2023 | 51,517 | $2.25M | |
| 2024incomplete | 62,848 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 37,380 | 33,002 | $3.22M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 23,079 | 20,609 | $2.75M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.0% | 5,461 | 5,267 | $580K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.2% | 4,280 | 4,143 | $500K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.6% | 4,172 | 4,047 | $444K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.3% | 3,170 | 2,906 | $314K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.0% | 27,430 | 22,017 | $291K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.8% | 21,283 | 20,196 | $173K |
| 99051 | 1.7% | 14,113 | 12,691 | $165K | |
| D1206 | Topical application of fluoride varnish | 1.4% | 5,424 | 5,331 | $134K |
| 92551 | 1.3% | 13,722 | 13,205 | $128K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 9,389 | 8,736 | $115K |
65 more codes
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.1% | 388 | $101K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 5,577 | $88K |
| 90686 | <1% | 3,809 | $83K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,210 | $74K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,380 | $68K |
| 99177 | <1% | 7,609 | $37K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 274 | $33K |
| 96127 | <1% | 5,543 | $29K | |
| 90670 | <1% | 1,064 | $24K | |
| 90698 | <1% | 829 | $19K | |
| 90680 | <1% | 795 | $18K | |
| 90651 | <1% | 749 | $17K | |
| 99173 | <1% | 7,548 | $17K | |
| 90671 | <1% | 744 | $16K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 80 | $14K |
| 90697 | <1% | 584 | $13K | |
| 96160 | <1% | 4,269 | $13K | |
| 90633 | <1% | 554 | $12K | |
| 90656 | <1% | 521 | $12K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 321 | $11K |
| 90620 | <1% | 475 | $11K | |
| 87807 | <1% | 925 | $10K | |
| 90619 | <1% | 336 | $8K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 26 | $7K |
| 92567 | <1% | 434 | $7K | |
| 99495 | <1% | 27 | $5K | |
| 90715 | <1% | 174 | $4K | |
| 90744 | <1% | 181 | $4K | |
| 94760 | <1% | 2,759 | $4K | |
| 81002 | <1% | 1,444 | $4K | |
| 90734 | <1% | 172 | $4K | |
| 96161 | <1% | 1,323 | $4K | |
| 99381 | <1% | 29 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 118 | $3K |
| 90710 | <1% | 113 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 68 | $2K |
| 90696 | <1% | 83 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 106 | $2K |
| 90716 | <1% | 54 | $1K | |
| 90707 | <1% | 42 | $861.36 | |
| 94664 | <1% | 68 | $798.48 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 68 | $756.50 |
| 90700 | <1% | 29 | $661.84 | |
| 90648 | <1% | 26 | $592.00 | |
| 88720 | <1% | 100 | $414.20 | |
| 91321 | <1% | 17 | $395.76 | |
| 81025 | <1% | 58 | $378.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 53 | $348.74 |
| 99072 | <1% | 5,905 | $337.50 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 17 | $186.60 |
| 80305 | <1% | 12 | $135.26 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 13 | $71.95 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 55 | $54.00 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 15 | $25.23 |
| 36415 | Collection of venous blood by venipuncture | <1% | 14 | $21.00 |
| 36416 | <1% | 82 | $18.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 68 | $12.99 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 764 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 480 | $0.00 |
| 87299 | 0% | 1,084 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 1,294 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,936 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 1,425 | $0.00 |
| G9521 | Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months | 0% | 177 | $0.00 |
| G9432 | Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMASOOD, SAQIB (OWNER)